Cargando…

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer

The multidrug-resistant (MDR) phenotype is usually accompanied by an abnormal expression of histone deacetylase (HDAC). Given that HDAC is vital in chromatin remodeling and epigenetics, inhibiting the role of HDAC has become an important approach for tumor treatment. However, the effect of HDAC inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Lixia, Zhao, Shaorong, Yang, Qianxi, Shi, Zhendong, Liu, Jingjing, Pan, Teng, Zhou, Dongdong, Zhang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962870/ https://www.ncbi.nlm.nih.gov/pubmed/33738256 http://dx.doi.org/10.3389/fonc.2021.614458

Ejemplares similares

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling
por: Yang, Qianxi, et al.
Publicado: (2021)

Modulated electro‐hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro
por: Vancsik, Tamas, et al.
Publicado: (2019)

Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer
por: Li, Jieqing
Publicado: (2023)

Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
por: Li, Xinyang, et al.
Publicado: (2022)

Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
por: Gui, Lin, et al.
Publicado: (2021)

Chidamide in the treatment of peripheral T-cell lymphoma
por: Chan, Thomas S, et al.
Publicado: (2017)

Chidamide, a histone deacetylase inhibitor, induces growth arrest and apoptosis in multiple myeloma cells in a caspase-dependent manner
por: Yuan, Xiang-Gui, et al.
Publicado: (2019)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Chidamide Inhibits Aerobic Metabolism to Induce Pancreatic Cancer Cell Growth Arrest by Promoting Mcl-1 Degradation
por: He, Mu, et al.
Publicado: (2016)

Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Chidamide combined with paclitaxel effectively reverses the expression of histone deacetylase in lung cancer
por: Zhang, Na, et al.
Publicado: (2020)

Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2023)

Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
por: Yang, Chendong, et al.
Publicado: (2018)

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma
por: Xue, Kai, et al.
Publicado: (2021)

Upregulation of CD22 by Chidamide promotes CAR T cells functionality
por: Yang, Xin, et al.
Publicado: (2021)

Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
por: Xue, Chaojun, et al.
Publicado: (2016)

Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells
por: Azizi, Ebrahim, et al.
Publicado: (2022)

Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells
por: Tian, Xiaoxue, et al.
Publicado: (2022)

Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression
por: Huang, Yuan, et al.
Publicado: (2017)

Absence of p53 in Clara cells favours multinucleation and loss of cell cycle arrest
por: Armit, Christopher J, et al.
Publicado: (2002)

Cell Cycle Arrest and Cell Survival Induce Reverse Trends of Cardiolipin Remodeling
por: Chao, Yu-Jen, et al.
Publicado: (2014)

Phase I Study of Intravenous PSC‐833 and Doxorubicin: Reversal of Multidrug Resistance
por: Minami, Hironobu, et al.
Publicado: (2001)

Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
por: Wang, Xing-Tong, et al.
Publicado: (2020)

Doxorubicin-Loaded Iron Oxide Nanoparticles Induce Oxidative Stress and Cell Cycle Arrest in Breast Cancer Cells
por: Hernandes, Elisa Parcero, et al.
Publicado: (2023)

Exploring the effect of chidamide on blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
por: Wang, Shunan, et al.
Publicado: (2018)

Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer
por: Hao, Xiaomeng, et al.
Publicado: (2021)

Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
por: Wang, He-Wen, et al.
Publicado: (2020)

Conditional inactivation of PDCD2 induces p53 activation and cell cycle arrest
por: Granier, Celine J., et al.
Publicado: (2014)

Cell cycle exits and U-turns: Quiescence as multiple reversible forms of arrest
por: Johnson, Martha Sharisha, et al.
Publicado: (2023)

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
por: Zhao, Haijun, et al.
Publicado: (2022)

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.
por: Punt, C. J., et al.
Publicado: (1997)

Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells
por: Pienta, K. J., et al.
Publicado: (2021)

P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest
por: Shamseddine, A A, et al.
Publicado: (2015)

Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas
por: Moreno, Carlos S., et al.
Publicado: (2007)

Sophisticated Framework between Cell Cycle Arrest and Apoptosis Induction Based on p53 Dynamics
por: Hamada, Hiroyuki, et al.
Publicado: (2009)

Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53
por: Li, Frank Q., et al.
Publicado: (2007)

Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
por: An, Duopeng, et al.
Publicado: (2021)

Cancer reversion with oocyte extracts is mediated by cell cycle arrest and induction of tumour dormancy
por: Saad, Norazalina, et al.
Publicado: (2018)

Synergistic effect of chidamide and venetoclax on apoptosis in acute myeloid leukemia cells and its mechanism
por: Li, Gangping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5mqb2sft03l9pvtgd692lhhbs